Editorial: Bone loss and gastric bypass surgery for morbid obesity

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 3, 2004, Pages 1059-1060

  Bell, Norman H ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; ESTROGEN; PARATHYROID HORMONE; PEPTIDE DERIVATIVE;

BODY MASS; BONE DENSITY; BONE MASS; CONCENTRATION (PARAMETERS); CROSS LINKING; DISEASE SEVERITY; EDITORIAL; ESTROGEN BLOOD LEVEL; FEMUR; GASTRIC BANDING; GASTROPLASTY; HUMAN; IMMUNOREACTIVITY; LAPAROSCOPY; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; MORBID OBESITY; OSTEOLYSIS; PREMENOPAUSE; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; SERUM; STOMACH BYPASS; SURGICAL TECHNIQUE; TREATMENT OUTCOME; URINALYSIS; WEIGHT REDUCTION; BONE REMODELING; NOTE;

BONE REMODELING; BONE RESORPTION; GASTRIC BYPASS; HUMANS; OBESITY, MORBID;

EID: 1642349527     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-032162     Document Type: Editorial

References (24)

1. Serdula MK, Mokdad AH, Williamson DF, Galuska DH, Mendlein JM, Heath GW 1999 Prevalence of attempting weight loss and strategies for controlling weight. JAMA 282:1353-1358
2. Bjorntorp P 1997 Obesity. Lancet 350:423-426
3. Safer DJ 1991 Diet, behavior modification, and exercise: a review of obesity treatments from a long-term perspective. South Med J 84:1470-1474
4. 1991 NIH Conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 115:956-961
5. Ott MT, Fanti P, Malluche HH, Ryo UY, Whaley FS, Strodel WE, Colacchi TA 1992 Biochemical evidence of metabolic bone disease in women following Roux-Y gastric bypass for morbid obesity. Obes Surg 2:341-348
6. Pugnale N, Giusti V, Suter M, Zysset F, Heraief E, Gaillard RC, Burckhardt P 2003 Bone metabolism and risk of secondary hyperparathyroidism 12 months after gastric banding in obese pre-menopausal women. Int J Obes Relat Metab Disord 27:110-116
7. Guney E, Kisakol G, Ozgen G, Yilmaz C, Yilmaz R, Kabalak T 2003 Effect of weight loss on bone metabolism: comparison of vertical banded gastroplasty and medical intervention. Obes Surg 13:383-388
8. Holdstock C, Engström BE, Öhrvall M, Lind L, Sundbom M, Karlsson FA 2003 Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 88:3177-3183
9. Liel Y, Edwards J, Shary J, Spicer KM, Gordon L, Bell NH 1988 The effects of race and body habitus on bone mineral density of the radius, hip, and spine in premenopausal women. J Clin Endocrinol Metab 66:1247-1250
10. Mazess RB, Barden HS, Drinka PJ, Bauwens SF, Orwoll ES, Bell NH 1990 Influence of age and body weight on spine and femur bone mineral density in U.S. white men. J Bone Miner Res 5:645-652
11. Lean JM, Jagger CJ, Chambers TJ, Chow JW 1995 Increased insulin-like growth factor I mRNA expression in rat osteocytes in response to mechanical stimulation. Am J Physiol 268:E318-E227
12. Duan Y, Parfitt A, Seeman E 1999 Vertebral bone mass, size, and volumetric density in women with spinal fractures. J Bone Miner Res 14:1796-1802
13. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S 1985 Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 76:370-373
14. Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH 1988 Low circulating vitamin D in obesity. Calcif Tissue Int 43:199-201
15. Compston JRE, Vedi S, Ledger JE, Webb A, Gazet JC, Pilkington TR 1981 Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr 34:2359-2363
16. Parfitt AM, Podenphant J, Villanueva AR, Frame B 1985 Metabolic bone diseases with and without osteomalacia after intestinal bypass surgery: a bone histomorphometric study. Bone 6:211-220
17. van Loan MD, Johnson HL, Barbieri TF 1998 Effect of weight loss on bone mineral content and bone mineral density in obese women. Am J Clin Nutr 67:734-738
18. Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR, Greenspan SL 2004 Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 89:1061-1065
19. Bell NH 2003 RANK ligand and the regulation of skeletal remodeling. J Clin Invest 111:1120-1122
20. Kudo O, Fujikawa Y, Itonaga I, Sabokbar A, Torisu T, Athanasou NA 2002 Proinflammatory cytokine (TNFα/IL-1α) induction of human osteoclast formation. J Pathol 198:220-227
21. Warne JP 2003 Tumour necrosis factor α: a key regulator of adipose tissue mass. J Endocrinol 177:351-355
22. Winkler G, Kiss S, Keszthelyi L, Sâpi Z, Öry I, Salamon F, Kovãcs M, Vargha P, Szekeres O, Speer G, Karãdi I, Sikter M, Kaszãs E, Dworak O, Gerö G, Cseh K 2003 Expression of tumor necrosis factor (TNF)-α position in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-α, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol 149:129-135
23. Yokota T, Meka CS, Medina KL, Igarashi H, Comp PC, Takahashi M, Nishida M, Oritani K, Miyagawa J, Funahashi T, Tomiyama Y, Matsuzawa Y, Kincade PW 2002 Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest 109:1303-1310
24. Lenchik L, Register TC, Hsu FC, Lohman K, Nicklas BJ, Freedman BI, Langefeld CD, Carr JJ, Bowden DW 2003 Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33:646-651